From pharmaceutical science to commercial scale.

KMS Pharma works with pharmaceutical companies on novel drug delivery systems, custom product development and complex or niche products, from the first formulation through clinical study, dossier and supply.

Programmes rarely fail because of a single laboratory, site, or consultant. More often, they stall at the handovers between them.

At KMS, our formulation, analytical, technology-transfer and regulatory scientists work as one integrated programme team. This ensures continuity from development through commercialisation—with the same technical understanding carried across every stage.

The product that leaves our laboratory is developed with the same end goal in mind: to reach the market successfully.

Products developed at KMS have been approved by regulators including the US FDA, the UK MHRA and Health Canada.V-07

One team

Formulation, analytical, technology-transfer and regulatory scientists on the same programme.

Complex products

Complex generics, novel drug delivery systems, sterile products, topical formulations, and differentiated reformulations across diverse therapeutic areas.

To the market

Dossiers, bioequivalence through research partners, and commercial supply.